Previous studies suggest that: the inhibition of IL-6 leads to a decreased STAT3 phosphorylation, which exacerbates cerebral ischemia, and the activation of STAT3 increases ischemic myocardial survival. Here, STAT3 is linked to Cerebral ischemia.